Molina Healthcare (MOH) stock declined by 1.31% due to analysts favoring Select Medical (SEM) over Molina in terms of overall business performance and potential upside based on various financial metrics, indicating a lack of confidence in Molina's growth prospects compared to its competitor.

Molina Healthcare (MOH) stock declined by 1

Molina Healthcare (MOH) stock fell by 0.68% following several major brokerage firms, including JPMorgan Chase and Cantor Fitzgerald, significantly lowering their price targets and maintaining a neutral rating on the stock after the company reported quarterly earnings that slightly missed estimates.

Molina Healthcare (MOH) stock fell by 0

Molina Healthcare (MOH) stock declined by 0.68% due to an ongoing investigation into possible securities fraud and disappointing second-quarter earnings that missed analyst expectations, compounded by increased medical cost pressures and a lowered full-year earnings guidance.

Molina Healthcare (MOH) stock declined by 0

Molina Healthcare (MOH) stock fell by 1.9% following a quarterly earnings report that slightly missed analyst expectations on EPS, as well as substantial target price reductions from multiple investment analysts.

Molina Healthcare (MOH) stock fell by 1

Molina Healthcare (MOH) stock experienced a decline of 1.9% likely due to a disappointing earnings report where it reported revenues that, while up 15.7%, did not meet analysts' expectations, compounded by the broader market trends affecting the health insurance segment.

Molina Healthcare (MOH) stock experienced a decline of 1

Molina Healthcare's stock (NYSE:MOH) declined by 0.5% following a significant reduction in its price target by Robert W. Baird from $373.00 to $179.00, coupled with other analyst downgrades and a slight earnings miss in its latest report.

Molina Healthcare's stock (NYSE:MOH) declined by 0

Molina Healthcare (MOH) stock experienced a 0.5% decline due to downgrades from multiple analysts, including Truist Financial, which lowered its price target significantly, indicating reduced expectations for the stock's performance.

Molina Healthcare (MOH) stock experienced a 0

Molina Healthcare (MOH) stock fell by 0.5% following Cantor Fitzgerald's downgrade of its price target from $312.00 to $210.00 and mixed ratings from other research firms, reflecting concerns over recent earnings performance that slightly missed analyst expectations.

Molina Healthcare (NYSE: MOH) stock fell by 0.5% following multiple brokerages, including UBS Group, Mizuho, and Morgan Stanley, downgrading their price targets and ratings on the stock, reflecting concerns about its financial performance and earnings miss in the recent quarterly results.

Molina Healthcare (NYSE: MOH) stock fell by 0

Molina Healthcare's stock (MOH) declined by 0.5% amid ongoing concerns stemming from an investigation into potential securities fraud and continuing financial struggles highlighted by missed earnings estimates and lowered full-year guidance due to increased medical costs.

Molina Healthcare's stock (MOH) declined by 0

Molina Healthcare (MOH) stock rose 4.3% due to increased institutional interest, with several hedge funds boosting their holdings in the company, particularly during the first quarter of 2025, despite a slight earnings miss in their latest report.

Molina Healthcare (MOH) stock rose 4

Molina Healthcare (MOH) stock fell 16.84% mainly due to broader market concerns and linkage to peers' earnings reports, where negative market reactions were observed, particularly after Elevance Health's disappointing performance.

Molina Healthcare (MOH) stock fell 16

Molina Healthcare's stock (MOH) fell by 3.57% ahead of its Q2 2025 earnings report, as market expectations may be tempered by recent trading activity, including insider selling and analysts adjusting price targets downward.

Molina Healthcare's stock (MOH) fell by 3

Molina Healthcare (MOH) stock decreased by 3.57% following a revision by Zacks Research, which lowered its EPS estimates for Q3 2025 from $5.72 to $5.71, amid a backdrop of mixed ratings and target price adjustments from several research firms.

Molina Healthcare (MOH) stock decreased by 3

Molina Healthcare (MOH) stock dropped by 10.41% as part of a broader decline in health insurers' shares, following disappointing earnings reports and investor reactions to corporate earnings news.

Molina Healthcare (MOH) stock dropped by 10

Molina Healthcare (MOH) stock dropped by 10.41% primarily due to Zacks Research lowering its Q1 2026 EPS estimates, anticipating earnings of $6.71 per share instead of the previous $6.82, which negatively impacted investor sentiment.

Molina Healthcare (MOH) stock dropped by 10.41% after Elevance Health lowered its financial outlook due to unexpectedly high costs associated with Medicaid and the Affordable Care Act, impacting investor sentiment across the healthcare insurance sector.

Molina Healthcare (NYSE:MOH) stock fell 5.47% due to analysts downgrading their ratings and price targets, indicating a lack of confidence in its future performance amidst mixed earnings results.

Molina Healthcare (NYSE:MOH) stock fell 5

Molina Healthcare's (MOH) stock rose by 0.68% after notable increases in institutional investments and strong quarterly earnings that surpassed analyst expectations. 

The stock increase can be attributed to significant buying activity from institutional investors, as well as positive financial results indicating revenue growth and strong earnings performance relative to market expectations.

Molina Healthcare's (MOH) stock rose by 0

Molina Healthcare's stock (MOH) fell by nearly 2% to a new 52-week low after Mizuho reduced its price target from $400 to $330, indicating concerns about the stock's value which contributed to the decline.

Molina Healthcare's stock (MOH) fell by nearly 2% to a new 52-week low after Mizuho reduced its pric

Molina Healthcare (MOH) stock fell by 3.64% following a reduction in Principal Financial Group's stake and various changes in institutional investor positions, alongside mixed analyst ratings affecting the market outlook. 

The stock likely declined due to Principal Financial Group Inc.'s decision to reduce its stake by 3.8%, which may signal a lack of confidence among investors, coupled with varied analyst reports that included downgrading some ratings.

Molina Healthcare (MOH) stock fell by 3

Molina Healthcare (MOH) stock fell by 3.64% due to significant selling by institutional investors, including Bank of New York Mellon Corp reducing its position, and insider selling by company executives.

Molina Healthcare (MOH) stock decreased by 0.68% likely due to profit-taking activities by insiders following a recent spike in stock price, as CEO Joseph M. Zubretsky and other directors sold significant portions of their shares.

Molina Healthcare (MOH) stock decreased by 0

Molina Healthcare (MOH) stock fell by 0.68% as Vontobel Holding Ltd. decreased its stake in the company by 16.9%, indicating potential bearish sentiment among institutional investors, despite recent strong earnings performance.

Molina Healthcare (MOH) stock fell by 2.91% after the company reduced its full-year profit expectations due to rising costs outpacing insurance premiums, projecting adjusted earnings of $21.50 to $22.50 per share instead of the previously estimated “at least $24.50.”

Molina Healthcare (MOH) stock fell by 2

Molina Healthcare's stock (MOH) fell by 2.91% due to the company's lower profit guidance resulting from rapidly accelerating costs, a situation that has also negatively impacted other healthcare stocks like UnitedHealth Group.

Molina Healthcare's stock (MOH) fell by 2

Molina Healthcare (MOH) stock fell nearly 3% after the company revised its profit guidance downward due to rapidly accelerating costs, amid a broader market decline influenced by increased trade tensions from the Trump administration and overall decreases in technology and consumer-related stocks.

Molina Healthcare (MOH) stock fell nearly 3% after the company revised its profit guidance downward 

Molina Healthcare (MOH) stock fell by 2.91% as the company lowered its profit guidance due to rapidly accelerating costs, amidst a broader market decline driven by concerns over increased tariffs announced by the Trump administration.

Molina Healthcare (MOH) stock fell 2.91% due to the company's lowered profit guidance amid rapidly accelerating costs, which aligns with the broader market decline influenced by increased pressure from the Trump administration on trading partners regarding tariff negotiations.

Molina Healthcare (MOH) stock fell 2

Molina Healthcare (MOH) stock plummeted by 21.97% due to negative investor sentiment following Centene's warning about lower enrollments and higher patient costs impacting profitability, which affected the entire healthcare sector.

Molina Healthcare (MOH) stock plummeted by 21

Molina Healthcare (MOH) stock rose 2.82% last night, benefiting from its consistent long-term outperformance and robust market capitalization of $14.91 billion, indicating strong investor confidence and financial health.

Molina Healthcare (MOH) stock rose 2

Molina Healthcare's stock (MOH) rose by 0.29% despite recent downgrades from several brokerages, attributed to positive quarterly earnings exceeding analysts' expectations and revenue growth, along with some analysts raising their price targets for the stock.

Molina Healthcare's stock (MOH) rose by 0

Molina Healthcare's stock (MOH) rose 2.06% last night due to strong quarterly earnings that exceeded analysts' expectations, coupled with positive upgrades from several equities research analysts.

Molina Healthcare's stock (MOH) rose 2

Molina Healthcare (MOH) stock declined by 1.05% due to recent adjustments in investor positions and analysts' mixed ratings, including a downgrade in price target by Barclays, indicating changing perceptions of the stock’s value.

Molina Healthcare (NYSE: MOH) stock experienced a slight decline of -0.13%, attributed to recent insider selling by the CEO and director and variations in investor sentiment as reflected in target price adjustments from various brokerages.

Molina Healthcare (NYSE: MOH) stock experienced a slight decline of -0

Molina Healthcare (MOH) stock recently rose by 1.01%, driven by increased institutional investment, positive earnings performance exceeding analyst expectations, and favorable research ratings from various financial analysts, indicating strong interest in the company's future prospects.

Molina Healthcare (MOH) stock recently rose by 1

Molina Healthcare's stock (MOH) rose by 1.01% due to significant institutional investment activity, with Farther Finance Advisors LLC increasing its stake by over 100%, and other investors also boosting their positions, alongside strong quarterly earnings that exceeded expectations.

Molina Healthcare's stock (MOH) rose by 1

Molina Healthcare (MOH) stock increased by 1.01% following favorable analyst upgrades and positive quarterly earnings results that surpassed expectations, leading to a consensus recommendation of "Hold" from brokers.

Molina Healthcare (MOH) stock increased by 1

Molina Healthcare (MOH) stock rose 0.74% due to increased institutional investment, favorable analyst ratings, and positive quarterly earnings results that exceeded expectations.

Molina Healthcare (MOH) stock rose 0

Molina Healthcare (MOH) stock fell by 2.65% partly due to significant insider sell-offs, including CEO Joseph M. Zubretsky and Director Richard M. Schapiro reducing their stakes, which may raise concerns among investors about the company's future performance.

Molina Healthcare (MOH) stock fell by 2.65% last night, despite having delivered strong annualized returns over the past 15 years, likely due to market fluctuations or investor sentiment.

Molina Healthcare (MOH) stock recently declined by 0.39%, attributed to a reduction in the stock's ratings by some analysts, including a downgrade by Baird R W from "strong-buy" to "hold" amidst changes in investors' positions and insider selling activity.

Molina Healthcare (MOH) stock recently declined by 0

Molina Healthcare (NYSE:MOH) stock fell by 0.36% due to a target price cut from Barclays, which reduced its estimate from $351.00 to $347.00 while maintaining an "equal weight" rating on the stock, indicating mixed sentiments from various analysts regarding its future performance.

Molina Healthcare (NYSE:MOH) stock fell by 0

Molina Healthcare (MOH) stock decreased by 0.44% following the recent initiation of coverage by Morgan Stanley with an overweight rating and a target price of $364.00, while the stock also faced significant insider selling which may have contributed to the decline.

Molina Healthcare (MOH) stock increased by 0.32% due to significant increases in positions by institutional investors, including a 217.2% boost from Wealth Enhancement Advisory Services and other large investments, showcasing strong investor interest and confidence in the company's growth potential.

Molina Healthcare (MOH) stock increased by 0

Molina Healthcare (MOH) stock experienced a decline of 1.26% following a target price reduction from Barclays, which lowered its estimate from $362.00 to $351.00, contributing to investor concerns despite other analysts upping their ratings.

Molina Healthcare (MOH) stock rose by 0.84% amid changes in institutional investments, positive earnings performance exceeding analyst expectations, and favorable upgrades from research firms. 

The stock increase is attributed to its strong quarterly earnings report that surpassed estimates and positive ratings adjustments from various analysts, reflecting confidence in the company's financial health and future prospects.

Molina Healthcare (MOH) stock rose by 0

Molina Healthcare (MOH) stock fell by 2.09% last night, attributed to insider selling and a generally cautious consensus rating from analysts, with most recommending a "Hold" on the stock.

Molina Healthcare's (MOH) stock experienced a decline of 1.47% last night, likely due to the overall market pressures affecting the healthcare sector, particularly the significant drop of competitor UnitedHealth Group, which has raised operational concerns and impacted investor sentiment.

Molina Healthcare's (MOH) stock experienced a decline of 1

Molina Healthcare (MOH) stock fell by 3.08% primarily due to insider selling, with CEO Joseph M. Zubretsky and Director Richard M. Schapiro both reducing their stakes significantly, which may have prompted concerns among investors about the company's future performance.

Molina Healthcare (MOH) stock fell by 3.08% following a reduction in stakes by institutional investors, including MIRAE ASSET GLOBAL ETFs, during the fourth quarter, indicating potential concerns about investor confidence or market dynamics affecting the stock.

Molina Healthcare (NYSE:MOH) stock declined by 2.0% last night despite its strong historical performance, likely due to investor reaction to market conditions or recent company updates, although specifics were not provided in the article.

Molina Healthcare (NYSE:MOH) stock declined by 2

Molina Healthcare's stock (MOH) rose by 0.25% following significant increases in institutional investments and strong quarterly earnings that exceeded expectations, signaling positive market sentiment.

Molina Healthcare (MOH) stock rose 3.62% due to positive adjustments from institutional investors and analysts upgrading their ratings and price targets following strong earnings and revenue performance.

Molina Healthcare (MOH) stock rose 3

Molina Healthcare (MOH) stock rose by 0.38% due to recent positive earnings results that exceeded analysts' expectations and upgraded price targets from various brokerages, reflecting investor confidence despite some decreased stakes by institutional investors.

Molina Healthcare's stock (MOH) increased by 0.5% last night as it has consistently outperformed the market over the past decade, with an annualized return reflecting strong financial performance, which likely contributed to investor confidence and the stock's rise.

MOH

Latest News & Analysis